AXGN
Price
$18.09
Change
-$0.34 (-1.84%)
Updated
Jan 17 closing price
Capitalization
348.67M
45 days until earnings call
VMD
Price
$8.15
Change
-$0.02 (-0.24%)
Updated
Jan 17 closing price
Capitalization
363.54M
39 days until earnings call
Ad is loading...

AXGN vs VMD

Header iconAXGN vs VMD Comparison
Open Charts AXGN vs VMDBanner chart's image
Axogen
Price$18.09
Change-$0.34 (-1.84%)
Volume$668.75K
Capitalization348.67M
Viemed Healthcare
Price$8.15
Change-$0.02 (-0.24%)
Volume$150.58K
Capitalization363.54M
AXGN vs VMD Comparison Chart
Loading...
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXGN vs. VMD commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXGN is a Hold and VMD is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (AXGN: $18.09 vs. VMD: $8.15)
Brand notoriety: AXGN and VMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AXGN: 164% vs. VMD: 107%
Market capitalization -- AXGN: $348.67M vs. VMD: $363.54M
AXGN [@Medical Specialties] is valued at $348.67M. VMD’s [@Medical Specialties] market capitalization is $363.54M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXGN’s FA Score shows that 0 FA rating(s) are green whileVMD’s FA Score has 0 green FA rating(s).

  • AXGN’s FA Score: 0 green, 5 red.
  • VMD’s FA Score: 0 green, 5 red.
According to our system of comparison, AXGN is a better buy in the long-term than VMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXGN’s TA Score shows that 4 TA indicator(s) are bullish while VMD’s TA Score has 4 bullish TA indicator(s).

  • AXGN’s TA Score: 4 bullish, 4 bearish.
  • VMD’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, VMD is a better buy in the short-term than AXGN.

Price Growth

AXGN (@Medical Specialties) experienced а +0.22% price change this week, while VMD (@Medical Specialties) price change was +2.52% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.94%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +1.30%.

Reported Earning Dates

AXGN is expected to report earnings on May 07, 2025.

VMD is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Medical Specialties (+0.94% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VMD($364M) and AXGN($349M) have the same market capitalization . AXGN YTD gains are higher at: 9.769 vs. VMD (1.621). VMD has higher annual earnings (EBITDA): 36.7M vs. AXGN (-13.33M). AXGN has more cash in the bank: 31M vs. VMD (12.8M). VMD has less debt than AXGN: VMD (10.3M) vs AXGN (69.3M). VMD has higher revenues than AXGN: VMD (183M) vs AXGN (159M).
AXGNVMDAXGN / VMD
Capitalization349M364M96%
EBITDA-13.33M36.7M-36%
Gain YTD9.7691.621603%
P/E RatioN/A37.52-
Revenue159M183M87%
Total Cash31M12.8M242%
Total Debt69.3M10.3M673%
FUNDAMENTALS RATINGS
AXGN vs VMD: Fundamental Ratings
AXGN
VMD
OUTLOOK RATING
1..100
7155
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
66
Overvalued
PROFIT vs RISK RATING
1..100
9273
SMR RATING
1..100
9473
PRICE GROWTH RATING
1..100
3554
P/E GROWTH RATING
1..100
10065
SEASONALITY SCORE
1..100
32n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AXGN's Valuation (49) in the Medical Specialties industry is in the same range as VMD (66) in the null industry. This means that AXGN’s stock grew similarly to VMD’s over the last 12 months.

VMD's Profit vs Risk Rating (73) in the null industry is in the same range as AXGN (92) in the Medical Specialties industry. This means that VMD’s stock grew similarly to AXGN’s over the last 12 months.

VMD's SMR Rating (73) in the null industry is in the same range as AXGN (94) in the Medical Specialties industry. This means that VMD’s stock grew similarly to AXGN’s over the last 12 months.

AXGN's Price Growth Rating (35) in the Medical Specialties industry is in the same range as VMD (54) in the null industry. This means that AXGN’s stock grew similarly to VMD’s over the last 12 months.

VMD's P/E Growth Rating (65) in the null industry is somewhat better than the same rating for AXGN (100) in the Medical Specialties industry. This means that VMD’s stock grew somewhat faster than AXGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXGNVMD
RSI
ODDS (%)
Bearish Trend 5 days ago
83%
Bullish Trend 5 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
81%
Bullish Trend 5 days ago
73%
Momentum
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 5 days ago
74%
MACD
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
83%
Bearish Trend 5 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 6 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 5 days ago
86%
View a ticker or compare two or three
Ad is loading...
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

AXGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXGN has been loosely correlated with ICUI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if AXGN jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXGN
1D Price
Change %
AXGN100%
-1.84%
ICUI - AXGN
39%
Loosely correlated
-1.32%
CERS - AXGN
36%
Loosely correlated
-1.65%
VMD - AXGN
34%
Loosely correlated
-0.24%
VCYT - AXGN
32%
Poorly correlated
-1.27%
SMLR - AXGN
32%
Poorly correlated
+11.06%
More

VMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, VMD has been loosely correlated with ICUI. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VMD jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VMD
1D Price
Change %
VMD100%
-0.24%
ICUI - VMD
43%
Loosely correlated
-1.32%
HBIO - VMD
38%
Loosely correlated
+0.52%
AVNS - VMD
36%
Loosely correlated
-0.81%
RDNT - VMD
35%
Loosely correlated
-1.68%
SGHT - VMD
35%
Loosely correlated
-0.35%
More